Medicine Description sitagliform 50/1000mg
sitagliform 50/1000mg tablets is a medication that combines metformin and sitagliptin to provide a multifaceted approach to glycemic control in adults with type II diabetes. Metformin primarily works by decreasing hepatic glucose production, enhancing insulin sensitivity, and improving peripheral glucose uptake and utilization. This helps in lowering blood sugar levels. Sitagliptin, on the other hand, is a DPP-4 inhibitor that prevents the degradation of incretin hormones. By increasing the levels of these hormones, sitagliptin promotes insulin secretion in response to meals and suppresses glucagon release, thereby contributing to improved postprandial glucose control. The synergistic effect of these two active ingredients addresses various mechanisms of glucose regulation, thereby providing more effective blood sugar management.
Indications and Uses of sitagliform 50/1000mg tablets
- Management of type II diabetes mellitus in adults.
- As an adjunct to diet and exercise for glycemic control.
- Used in patients who have not achieved adequate glycemic control with metformin alone.
Side Effects of sitagliform 50/1000mg tablets
- Nausea
- Diarrhea
- Headache
- Dizziness
- Hypoglycemia
- Abdominal discomfort
Storage and Handling
Store at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children.
Patient Advice and Precautions
Patients should be advised to monitor their blood sugar levels regularly and report any significant fluctuations to their healthcare provider. It is crucial to maintain a balanced diet and engage in regular physical activity. Patients should also be informed about the signs of hypoglycemia and how to manage it. Regular follow-up appointments are important to evaluate the effectiveness of the treatment and make necessary adjustments.